HEATHER TYSON: Open Payments
NPI 1609448539 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 38 payments from 12 companies in 2025. Trend: 2023 $880 · 2024 $868 · 2025 $833
Food & beverage: $833
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $168 |
| AstraZeneca Pharmaceuticals LP | 7 | $166 |
| Novo Nordisk Inc | 3 | $162 |
| Axsome Therapeutics, Inc. | 5 | $106 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Lilly USA, LLC | 2 | $48 |
| Lundbeck LLC | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Alkermes, Inc. | 1 | $19 |
Products named: Ozempic, AUSTEDO XR, FARXIGA, Auvelity, REXULTI, MOUNJARO, AIRSUPRA, UZEDY.
Industry payments across FL — which companies pay providers there.
